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observed secondary to traumatic induction of OA by anterior
cruciate ligament transection (ACLT).
Methods: Four groups of 10 female rats were subjected to ei-
ther sham or ACLT surgery in both knee joints and administered
twice a day for 28 days with an oral dose of salmon calci-
tonin (150mg/kg 5-CNAC + 2mg/kg calcitonin) or vehicle control
(150mg/kg 5-CNAC). Serum samples were collected at baseline
and 7, 14, 21 and 28 days and weights were recorded at reg-
ular intervals. Cartilage degradation was evaluated in serum by
C-terminal telopeptide of type II collagen (CTX-II ELISA). Knee
joints were collected at euthanasia and one was processed
for histology and immunohistochemistry (IHC). Sections were
scored on a modiﬁed Mankin score for proteoglycan content,
chondrocytes cloning and cartilage erosion on a scale from 0-4,
where the score 4 was most severe damage. Immunolocalization
of antibodies towards CTX-II fragments, MMP-13 expression and
proliferation (Ki67) was visualized by IHC.
Results: Treatment with salmon calcitonin signiﬁcantly reduced
serum CTX-II levels in sham+calcitonin animals on day 14 (52%,
P<0.05) and day 28 (49%, P<0.001), compared to the con-
trol group. Treatment with calcitonin also reduced CTX-II levels
in the ACLT+calcitonin groups on day 14 (50%, P<0.01) and
day 28 (41%, P<0.05), compared to the control group. ACLT
operated knees resulted in a 40% signiﬁcant (P<0.001) in-
crease in total Mankin score. Calcitonin restored Mankin score
to below sham levels, (P<0.05). The most promising effect was
observed on cartilage erosion. MMP-13 expression and CTX-II
fragments were co-localized in the articular cartilage surface in
the eroded areas. Serum CTX-I levels decreased in calcitonin
treated animals compared to sham operated animals (36%,
P<0.001).
Conclusions: Currently there are no treatments available for
OA. Calcitonin has recently been proposed as a potential treat-
ment for OA. These data are the ﬁrst to demonstrate that an oral
formulation of calcitonin protect against cartilage degradation in
an in vivo model of joint trauma and increased cartilage degra-
dation. The chondroprotective effect of salmon calcitonin may
be a combination of direct effects on chondrocytes in addition
to the well-established effect on bone resorption. Further clinical
studies are needed to validate the herein documented effects on
cartilage erosion.
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Purpose: The most frequently used model for osteoarthritis (OA)
is the canine joint instability, viz. ACLT, model. The ACLT model
can be extended with a medial meniscectomy (i.e., ACLT-Mx
model) to avoid unintentional, and with that variable, meniscal
damage. More recently the canine Groove model has been
developed in which OA is caused by surgically induced cartilage
damage combined with temporary intermittent forced loading of
the joint. Both models demonstrated comparable development
of cartilage damage but they have never been compared on
changes in gait as measure of pain/disability. Such a clinical
measure is, in addition to structural parameters of joint damage
and inﬂammation, of major importance in evaluation of treatment
strategies of OA.
Methods: Knee osteoarthritis (OA) was induced in Labrador
dogs according to the ACLT-Mx model (n=7) or Groove model
(n=7). Every four weeks standardized radiographs were taken
to analyze osteophyte formation. Every two weeks gait was
recorded using Force Plate Analysis (FPA). Joints were macro-
scopic, histological, and biochemical analyzed for features of OA,
12 weeks after induction of OA.
Results: Radiographs revealed osteophyte formation in the ex-
perimental joints at the expected locations and the overall os-
teophyte score increased signiﬁcantly (p<0.05) over time for
both models. Cartilage integrity was damaged as reﬂected by
an increased macroscopic ( 1.5 vs. 1), and histological score
( 3 vs. 2.5) and a decreased proteoglycan content (-29% vs.
-18%) for the ACLT-Mx model and Groove model, respectively
(all p<0.05). Chondrocyte activity demonstrated an increased
synthesis rate (+70% vs. +10%) and release of proteoglycans
(+200% vs. +60%) for the ACLT-Mx model and Groove model,
respectively (both p<0.05). Synovial inﬂammation revealed the
same characteristics in both models ( 3.5 vs. 1.0 and 1.2 vs. 0.8
for macroscopic and histological inﬂammation in the, ACLT-Mx vs.
Groove model, respectively). Gait analysis revealed, a decrease
in the three peak ground reaction forces of the experimental leg
after OA induction (p<0.05), ranging from -80% in the ACLT-MX
model to -40% in groove model, statistically different between
both models (p<0.05). On average the ACLT-Mx demonstrated
more pronounced changes compared to the Groove model. In-
terestingly, the change in gait (all three ground reaction forces)
correlated signiﬁcantly with the change in cartilage integrity (pro-
teoglycan content and histological grade; r=0.445, r=0.488, and
r=0.542 for peak braking, stance, and propelling force, respec-
tively; all p<0.003).
Conclusions: The ACLT-Mx model demonstrates all the charac-
teristics of OA and can be designated as a moderate to severe
model of OA with clear synovial inﬂammatory activity. The Groove
model is a less painful and signiﬁcantly milder model of OA. The
latter might be more suitable to study subtle changes as a result
of intervention than the more robust ACLT-Mx model. Moreover,
gait might be used as a surrogate measure of pain/disability.
Most important, degree of cartilage damage is reﬂected by the
extent to which the OA joint was (un)loaded.
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Purpose: Appropriate dosage of intra-articular injections of
drugs with potentially beneﬁcial structural or symptomatic ef-
fects on articular cartilage requires information on the cartilage
surface area, and potentially, on the cartilage thickness and vol-
ume. As various animal models are used to test the effect of
such drugs in preclinical models, the aim of the current study
was to provide quantitative, three-dimensional data on the tibial
cartilage surface areas, cartilage thickness and cartilage volume
in a variety of animal species and in humans.
Methods: The knees of 16 male Sprague Dawley rats (body
weight 300 g) and 6 rabbits (weight 3.5 kg) were investigated
with magnetic resonance imaging at 7 Tesla (T), and the knees
and the knees of 3 cats (weight 4.2 kg), 18 mongrel dogs (weight
25 kg), 1 pig (weight 110 kg), 1 horse (weight 535 kg) and 1
rhinoceros (weight 1200 kg) at 1.5T. The values were compared
